JP2009539965A5 - - Google Patents

Download PDF

Info

Publication number
JP2009539965A5
JP2009539965A5 JP2009514931A JP2009514931A JP2009539965A5 JP 2009539965 A5 JP2009539965 A5 JP 2009539965A5 JP 2009514931 A JP2009514931 A JP 2009514931A JP 2009514931 A JP2009514931 A JP 2009514931A JP 2009539965 A5 JP2009539965 A5 JP 2009539965A5
Authority
JP
Japan
Prior art keywords
influenza virus
vaccine
adjuvant
dose
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009514931A
Other languages
English (en)
Japanese (ja)
Other versions
JP5566687B2 (ja
JP2009539965A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2007/002724 external-priority patent/WO2007144772A2/en
Publication of JP2009539965A publication Critical patent/JP2009539965A/ja
Publication of JP2009539965A5 publication Critical patent/JP2009539965A5/ja
Application granted granted Critical
Publication of JP5566687B2 publication Critical patent/JP5566687B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009514931A 2006-06-15 2007-06-15 アジュバントを使用しない複数回投与ワクチン接種レジメン Active JP5566687B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81466506P 2006-06-15 2006-06-15
US60/814,665 2006-06-15
PCT/IB2007/002724 WO2007144772A2 (en) 2006-06-15 2007-06-15 Adjuvant-sparing multi-dose influenza vaccination regimen

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014037950A Division JP5981951B2 (ja) 2006-06-15 2014-02-28 アジュバントを使用しない複数回投与ワクチン接種レジメン

Publications (3)

Publication Number Publication Date
JP2009539965A JP2009539965A (ja) 2009-11-19
JP2009539965A5 true JP2009539965A5 (https=) 2010-07-15
JP5566687B2 JP5566687B2 (ja) 2014-08-06

Family

ID=38832174

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009514931A Active JP5566687B2 (ja) 2006-06-15 2007-06-15 アジュバントを使用しない複数回投与ワクチン接種レジメン
JP2014037950A Active JP5981951B2 (ja) 2006-06-15 2014-02-28 アジュバントを使用しない複数回投与ワクチン接種レジメン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014037950A Active JP5981951B2 (ja) 2006-06-15 2014-02-28 アジュバントを使用しない複数回投与ワクチン接種レジメン

Country Status (17)

Country Link
US (3) US20090220545A1 (https=)
EP (1) EP2032163B1 (https=)
JP (2) JP5566687B2 (https=)
KR (1) KR20090016704A (https=)
CN (1) CN101500603A (https=)
AU (1) AU2007258874B2 (https=)
BR (1) BRPI0713150A8 (https=)
CA (1) CA2657989A1 (https=)
CY (1) CY1114315T1 (https=)
DK (1) DK2032163T3 (https=)
EA (1) EA017441B1 (https=)
ES (1) ES2401484T3 (https=)
PL (1) PL2032163T3 (https=)
PT (1) PT2032163E (https=)
SI (1) SI2032163T1 (https=)
WO (1) WO2007144772A2 (https=)
ZA (1) ZA200810582B (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11707520B2 (en) 2005-11-03 2023-07-25 Seqirus UK Limited Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
CA2628152C (en) * 2005-11-04 2016-02-02 Novartis Vaccines And Diagnostics S.R.L. Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
JP5518041B2 (ja) * 2008-03-18 2014-06-11 ノバルティス アーゲー インフルエンザウイルスワクチン抗原の調製における改良
GB0905570D0 (en) * 2009-03-31 2009-05-13 Novartis Ag Combined vaccines
EP3173097A3 (en) 2009-02-10 2017-07-12 Seqirus UK Limited Influenza vaccines with reduced amounts of squalene
KR101176305B1 (ko) * 2009-10-14 2012-08-23 웅진코웨이주식회사 붉나무 추출물을 포함하는 인플루엔자 바이러스 감염의 예방용 조성물, 상기 조성물을 포함하는 기상필터 및 상기 필터를 포함하는 공기청정기
KR101153630B1 (ko) * 2009-10-16 2012-06-18 웅진코웨이주식회사 타닌산을 포함하는 인플루엔자 바이러스 감염의 예방용 조성물, 상기 조성물을 포함하는 기상필터 및 상기 필터를 포함하는 공기청정기
US20110126501A1 (en) 2009-10-16 2011-06-02 Woongjin Coway Co., Ltd. Composition for prevention of influenza viral infection comprising tannic acid, air filter comprising the same and air cleaning device comprising the filter
WO2011102873A1 (en) * 2010-02-21 2011-08-25 Innovative Bottles, Llc Biodegradable pharmacy container and safety cap
EP2525815B1 (en) * 2010-01-24 2015-02-25 Novartis AG Irradiated biodegradable polymer microparticles
US8852157B2 (en) 2010-02-21 2014-10-07 Innovative Bottles, Llc Disposable items made from bioplastic resins
PL2569007T3 (pl) * 2010-05-11 2016-04-29 Intervet Int Bv Szczepionka przeciwko Mycoplasma Hyopneumoniae, odpowiednia do podawania w obecności przeciwciał pochodzących od matki
WO2012117377A1 (en) * 2011-03-02 2012-09-07 Novartis Ag Combination vaccines with lower doses of antigen and/or adjuvant
WO2016011343A1 (en) 2014-07-17 2016-01-21 The Trustees Of The University Of Pennsylvania Her3 peptides and dendritic cell vaccines
WO2016068333A1 (ja) * 2014-10-30 2016-05-06 中外製薬株式会社 シリンジキャップを具備した、針付プレフィルドシリンジ製剤
US10406290B2 (en) 2015-02-03 2019-09-10 Merz Pharma Gmbh & Co. Kgaa Botulinum toxin prefilled plastic syringe
US11013795B2 (en) 2015-06-26 2021-05-25 Seqirus UK Limited Antigenically matched influenza vaccines
CA2992925A1 (en) * 2015-07-17 2017-01-26 The Trustees Of The University Of Pennsylvania Identification of immunogenic mhc class ii peptides for immune-based therapy
ES2991988T3 (es) 2017-10-30 2024-12-05 Takeda Pharmaceuticals Co Detergentes compatibles con el medio ambiente para la inactivación de virus con envoltura lipídica
WO2019121513A1 (en) 2017-12-18 2019-06-27 Intervet International B.V. Swine influenza a virus vaccine
US12343390B2 (en) 2018-08-07 2025-07-01 Wisconsin Alumni Research Foundation (Warf) Recombinant biologically contained filovirus vaccine
EP3921413A1 (en) 2019-02-08 2021-12-15 Wisconsin Alumni Research Foundation (WARF) Humanized cell line
US11807872B2 (en) 2019-08-27 2023-11-07 Wisconsin Alumni Research Foundation (Warf) Recombinant influenza viruses with stabilized HA for replication in eggs
JP2023511444A (ja) 2020-01-24 2023-03-17 ウィスコンシン アルムニ リサーチ ファンデイション 安定化されたnaを有する組換えインフルエンザウイルス
WO2021195410A1 (en) 2020-03-25 2021-09-30 Wisconsin Alumni Research Foundation (Warf) Recombinant multivalent influenza viruses

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990001947A1 (en) 1988-08-25 1990-03-08 The Liposome Company, Inc. Affinity associated vaccine
AU631377B2 (en) * 1988-08-25 1992-11-26 Liposome Company, Inc., The Affinity associated vaccine
GB9923176D0 (en) * 1999-09-30 1999-12-01 Smithkline Beecham Biolog Novel composition
DE10012370A1 (de) * 2000-03-14 2001-09-27 Chiron Behring Gmbh & Co Adjuvans für Vakzinen
DK1635863T3 (da) * 2003-06-17 2010-11-22 Mannkind Corp Sammensætninger til udløsning, forbedring og opretholdelse af immunresponser mod MHC-klasse-i-begrænsede epitoper til profylaktiske eller terapeutiske formål
JP5600375B2 (ja) * 2004-03-09 2014-10-01 ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド インフルエンザウイルスワクチン
AR054020A1 (es) 2005-03-23 2007-05-30 Glaxosmithkline Biolog Sa Nuevo uso
AU2006310338A1 (en) * 2005-11-04 2007-05-10 Novartis Vaccines And Diagnostics Srl Adminstration routes for priming/boosting with influenza vaccines
TWI457133B (zh) * 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
MX2009000660A (es) 2006-07-17 2009-04-08 Glaxosmithkline Biolog Sa Vacuna de influenza.

Similar Documents

Publication Publication Date Title
JP2009539965A5 (https=)
JP2011504486A5 (https=)
JP2014532620A5 (https=)
JP2004527264A5 (https=)
MX2010008468A (es) Acidos nucleicos de la formula (i) (nug1xmgnnv)a y derivados de los mismos como un agente/adyuvante inmunoestimulante.
HRP20190876T1 (hr) Novi adjuvantirani pripravci
ATE309821T1 (de) Influenzavirus-impfstoffzusammensetzung
EP4368202A3 (en) Attenuated viruses useful for vaccines
RU2015132962A (ru) Иммуногенные композиции на основе вируса гриппа и их применение
JP2019526580A5 (https=)
JP2016506416A5 (https=)
CY1116108T1 (el) Εμβολιο ιου ερπητα ζωστηρα
EP4233898A3 (en) Influenza mrna vaccines
FI4023249T3 (fi) Nukleiinihapporokotteita
WO2008014521A8 (en) Improved vaccines and methods for using the same
JP2016508999A5 (https=)
JP2014521605A5 (https=)
JP2011515490A5 (https=)
BRPI0419023A (pt) vacina contra poliomielite inativada e derivada do genero sabin de vìrus da polio
JP2009514839A5 (https=)
JP2009514840A5 (https=)
JP2006512078A5 (https=)
AU2017261706A1 (en) Inactivating pathogens and producing highly immunogenic inactivated vaccines using a dual oxidation process
JP2019510064A5 (https=)
JP2009518410A5 (https=)